Literature DB >> 10458324

Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy.

F Williams1, A Meenagh, A P Maxwell, D Middleton.   

Abstract

High-resolution polymerase chain reaction using sequence-specific oligonucleotide probes (PCR-SSOP) typing methods for HLA-A identification have been established. The four systems, which operate independently of each other, are intended for use as secondary typing systems following HLA-A identification with a medium-resolution PCR-SSOP technique. The systems, all using digoxigenin-labelled probes, are based on group specific amplifications for resolution of: i) HLA-A*29 & -A*33; ii) HLA-A*24 & -A*30; and iii) HLA-A*26, -A*25, -A*11, -A*34, -A*66 and -A*68 alleles, respectively. The fourth system, for the detection of HLA-A*02 alleles, is a modification of a previously reported PCR-SSOP subtyping system. The methods have been applied to individuals from the local bone marrow registry and HLA-A allele frequencies for the Northern Ireland population have been established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458324     DOI: 10.1034/j.1399-0039.1999.540107.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

2.  Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Authors:  S J Mack; P Cano; J A Hollenbach; J He; C K Hurley; D Middleton; M E Moraes; S E Pereira; J H Kempenich; E F Reed; M Setterholm; A G Smith; M G Tilanus; M Torres; M D Varney; C E M Voorter; G F Fischer; K Fleischhauer; D Goodridge; W Klitz; A-M Little; M Maiers; S G E Marsh; C R Müller; H Noreen; E H Rozemuller; A Sanchez-Mazas; D Senitzer; E Trachtenberg; Marcelo Fernandez-Vina
Journal:  Tissue Antigens       Date:  2013-04

3.  Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.

Authors:  Deborah Kronenberg; Robin R Knight; Megan Estorninho; Richard J Ellis; Michel G Kester; Arnoud de Ru; Martin Eichmann; Guo C Huang; Jake Powrie; Colin M Dayan; Ania Skowera; Peter A van Veelen; Mark Peakman
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

4.  HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Authors:  Eric Mbunwe; Bart J Van der Auwera; Ilse Vermeulen; Simke Demeester; Annelien Van Dalem; Eric V Balti; Sara Van Aken; Luc Derdelinckx; Harry Dorchy; Jean De Schepper; Chris van Schravendijk; Janet M Wenzlau; John C Hutton; Daniël Pipeleers; Ilse Weets; Frans K Gorus
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

5.  Diversity of extended HLA-DRB1 haplotypes in the Finnish population.

Authors:  Annika Wennerström; Efthymia Vlachopoulou; L Elisa Lahtela; Riitta Paakkanen; Katja T Eronen; Mikko Seppänen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

6.  Circulating β cell-specific CD8+ T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes.

Authors:  L Yeo; I Pujol-Autonell; R Baptista; M Eichmann; D Kronenberg-Versteeg; S Heck; G Dolton; A K Sewell; T Härkönen; M-L Mikk; J Toppari; R Veijola; M Knip; J Ilonen; M Peakman
Journal:  Clin Exp Immunol       Date:  2019-11-10       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.